
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
Keywords: گیرنده فاکتور رشد اپیدرمال (EGFR); Carcinoma; Non-small-cell lung; Epidermal growth factor receptor (EGFR); Erlotinib; Asian; Caucasian; Chemotherapy; Tyrosine kinase inhibitor (TKI);